HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Cotrimoxazole induced dermatitis and curative treatment of AIDS pneumocystosis].

Abstract
Adverse cutaneous reactions frequently occur during the treatment of AIDS associated pneumocystosis by trimethoprime-sulfamethoxazole. The most common form is a maculous rash. Treating throughout the duration of hypersensitivity may lead to potentially lethal Stevens-Johnson and Lyell syndromes. Slow acetylator phenotype, a glutathion deficiency and a history of adverse cutaneous reactions have been identified as risk factors of cutaneous reactions. An adjuvant corticosteroid therapy decreases the frequency of adverse cutaneous reactions during the treatment of hypoxaemic pneumocystosis by trimethoprim-sulfamethoxazole.
AuthorsE Caumes
JournalRevue des maladies respiratoires (Rev Mal Respir) Vol. 13 Issue 2 Pg. 101-6 ( 1996) ISSN: 0761-8425 [Print] France
Vernacular TitleToxidermies au cotrimoxazole et traitement curatif de la pneumocystose du SIDA.
PMID8711227 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Anti-Infective Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination
Topics
  • AIDS-Related Opportunistic Infections (drug therapy)
  • Anti-Infective Agents (adverse effects)
  • Drug Eruptions (etiology, physiopathology)
  • Humans
  • Incidence
  • Pneumonia, Pneumocystis (drug therapy)
  • Risk Factors
  • Stevens-Johnson Syndrome (chemically induced, etiology)
  • Treatment Outcome
  • Trimethoprim, Sulfamethoxazole Drug Combination (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: